Tag Archives: FDA

Throughout December last year, Insys Therapeutics Inc (NASDAQ:INSY) flat lined around $9 a share. Despite continued effort by management to maintain a positive news flow, and in turn, to buoy positive sentiment, the company couldn’t break...

Our regular readers will know that Peregrine Pharmaceuticals (NASDAQ:PPHM) is one of the companies we have long highlighted as one that we see as being undervalued, and by proxy, due a revaluation. On a number of occasions over the last few...

At the end of January, Novan Inc (NASDAQ:NOVN) published data from its lead acne trials, and the company took a severe hit on the back of the numbers. From a PPS of around $20, markets traded Novan down to less than $5 a share, pushing the...

On the release of some data early this week Zosano Pharma Corp (NASDAQ:ZSAN) ran up more than 75%, and a small correction aside, has held on to the majority of these gains for the subsequent forty eight hours. At time of writing, US afternoon...

Aviragen Therapeutics Inc (NASDAQ:AVIR) is not having a good week. The company just put out data from a phase 2 study of its lead development asset, and has taken a close to 40% hit on the news. Ahead of market open on Wednesday, it looks as...

Galectin Therapeutics Inc (NASDAQ:GALT) is drawing some considerable volume at the moment, and the company is up more than 45% this week alone as a result. Year to date, this number rises to 84%. From a purely quantitative perspective, it has...

At the end of last year, we published this article, highlighting Peregrine Pharmaceuticals (NASDAQ:PPHM) as being a company to watch. The article was rooted in this conclusion: there is only so much time Peregrine can spend at its then-current...

Acura Pharmaceuticals, Inc.(NASDAQ:ACUR) started out this week at circa $0.5 a share. By mid week, it had risen to more than $1.3, and currently trades for just shy of $1. The correction might be an opportunity to get in ahead of a return to...

While the majority of our competitors have warned investors away from Anavex Life Sciences Corp. (NASDAQ:AVXL) over the last six months, here at Insider Financial we have repeatedly highlighted the company as having the potential to offer investors...

Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) was basically flat throughout late January, but this week has really started to run, on a couple of updates relating to the company’s pipeline. There looks to be plenty of run room left, even...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter